Search

everythinglearnresearchcommunity

for

Search:↓

A man with rare Lichen Planopilaris lost body hair, not scalp hair, and treatment stopped itching but didn't regrow hair.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

Managing frontal fibrosing alopecia and lichen planus pigmentosus is challenging due to resistant hair loss and skin discoloration.

Platelet-rich plasma (PRP) may help treat hair loss in patients with frontal fibrosing alopecia who don't respond to other treatments.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

Light therapy reduces scalp inflammation, boosts hair regrowth with Minoxidil 2%.

A specific drug can help treat Lichen Planopilaris, a condition causing permanent hair loss.

A bull got very sick and had to be put down after eating hairy vetch for months.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Treatment with plasma rich in growth factors improved hair density and thickness for hair loss patients.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Lichen planopilaris in men often involves scalp redness and itching, with some also having hair loss, mucosal lichen planus, or thyroid disease, and treatment improved symptoms in nearly half of the cases.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Finasteride may help treat frontal fibrosing alopecia, but more research is needed.

A horse with severe hair loss was diagnosed with alopecia areata and a yeast infection.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

A rare scalp disease causes hair loss, pus-filled nodules, and scarring.

Melanocytes may trigger the immune response in alopecia areata, affecting hair regrowth.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Hair loss in mice starts with immune cells damaging hair roots before it becomes visible.

Alternative treatments show promise for hair growth beyond traditional methods.

The document concludes that recognizing specific histological features of different nonscarring alopecias is crucial for accurate diagnosis and understanding hair loss progression.

Trichoscopy helps diagnose hairline recession causes in Egyptian women, with androgenetic alopecia being the most common.

Hair loss in males involves inflammation, collagen buildup, and follicle damage, with severity increasing with age and baldness duration.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Hair loss can be caused by cancer, treatments, or skin conditions, and trichoscopy helps diagnose it.